Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human, Mouse

Applications

Validated:

Flow Cytometry

Cited:

Flow Cytometry, Immunocytochemistry, CAR-T (Flow Cytometry)

Label

Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)

Antibody Source

Monoclonal Mouse IgG1 Clone # QBEnd10
Loading...

Product Specifications

Immunogen

Human endothelial vesicles

Specificity

Detects human CD34 in direct ELISAs.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1

Scientific Data Images for Human CD34 APC‑conjugated Antibody

Detection of CD34 antibody in Human PBMCs antibody by Flow Cytometry.

Detection of CD34 in Human PBMCs by Flow Cytometry.

Human peripheral blood mononuclear cells (PBMCs) were stained with Mouse Anti-Human CD34 APC-conjugated Monoclonal Antibody (Catalog # FAB7227A) and Mouse Anti-Human CD45 PE-conjugated Monoclonal Antibody (Catalog # FAB1430P). Quadrant markers were set based on control antibody staining (Catalog # IC002A). View our protocol for Staining Membrane-associated Proteins.
Detection of CD34 antibody in KG-1a Human Cell Line antibody by Flow Cytometry.

Detection of CD34 in KG‑1a Human Cell Line by Flow Cytometry.

KG-1a human acute myelogenous leukemia cell line was stained with Mouse Anti-Human CD34 APC-conjugated Monoclonal Antibody (Catalog # FAB7227A, filled histogram) or isotype control antibody (Catalog # IC002A, open histogram). View our protocol for Staining Membrane-associated Proteins.
Detection of Human CD34 by Flow Cytometry

Detection of Human CD34 by Flow Cytometry

alpha beta, V delta 1+, and V delta 2+ T Cells Are Efficiently Transduced with GD2-CAR following Activation with CD3/CD28 Antibody, ZOL, or ConA, and Bulk Populations Are Cytotoxic to Neuroblastoma Cells(A) Representative flow cytometry dot plot showing transduction efficiency of ZOL-expanded non-transduced and GD2-CAR+-transduced PBMCs. V delta 2+ populations were gated on CD3+ live cells 8 days following transduction. The GD2-CAR construct coexpresses the QBend10 epitope from CD34, allowing detection by flow cytometry. Transduction efficiency was determined by the percentage of QBend10+ in the T cell population gate compared to control non-transduced cells. (B–D) Mean transduction efficiency using CD3/CD28 antibody, ZOL, or ConA activation methods, respectively. Each data point represents an individual donor (n = 9) and each horizontal line is the mean. (E–G) Bulk populations of GD2-CAR-transduced T cells stimulated by CD3/CD28 antibody (E), ZOL (F), and ConA (G) specifically lyse the GD2-expressing neuroblastoma cell line, LAN1, in 4-hr 51Cr release assay. NTD, non-transduced T cells; TD, transduced GD2-CAR+ T cells (data represented as mean ± SEM; 3–5 individual donors in triplicate). Image collected and cropped by CiteAb from the following publication (https://linkinghub.elsevier.com/retrieve/pii/S1525001617305981), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Human CD34 by Flow Cytometry

Detection of Human CD34 by Flow Cytometry

Memory Phenotype and Exhaustion Marker Expression on Expanded CD3+ alpha beta, V delta 1+, and V delta 2+ Live T Cells(A) Representative flow cytometry dot plot showing gating of T cell subtypes ( alpha beta, V delta 1+, and V delta 2+) and contour plots of the corresponding subtype memory phenotype (N, naive; CM, central memory; EM, effector memory; TEMRA, terminally differentiated effector memory) according to expression of CD27 and CD45RA. (B–D) memory phenotypes of pre-expanded PBMCs (B), post-expansion non-transduced (NTD) cells (C), and post-expansion GD2-CAR-transduced cells (D). alpha beta cells were stimulated with CD3/CD28 antibody, V delta 1 cells were stimulated with ConA, and V delta 2 cells were stimulated with ZOL (data represented as mean ± SEM; alpha beta and V delta 2, n = 6; V delta 1, n = 3). (E and F) Expanded V delta 1+ cells transduced with CAR after ConA stimulation express significantly fewer exhaustion markers (PD1 and TIM3) than alpha beta and V delta 2+ CAR-T cells. (E) Flow cytometry plots from a representative donor. alpha beta cells were stimulated with CD3/CD28 antibody, V delta 1+ cells were stimulated with ConA, and V delta 2+ cells were stimulated with ZOL. (F) PD1 and TIM3 expression on TD and NTD T cells 13 days following activation (data represented as mean ± SEM; alpha beta and V delta 2+, n = 6; V delta 1+, n = 3; p value for significance comparing double-negative populations). Image collected and cropped by CiteAb from the following publication (https://linkinghub.elsevier.com/retrieve/pii/S1525001617305981), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Human Human CD34 APC-conjugated Antibody by Flow Cytometry

Detection of Human Human CD34 APC-conjugated Antibody by Flow Cytometry

alpha beta, V delta 1+, and V delta 2+ T Cells Are Efficiently Transduced with GD2-CAR following Activation with CD3/CD28 Antibody, ZOL, or ConA, and Bulk Populations Are Cytotoxic to Neuroblastoma Cells(A) Representative flow cytometry dot plot showing transduction efficiency of ZOL-expanded non-transduced and GD2-CAR+-transduced PBMCs. V delta 2+ populations were gated on CD3+ live cells 8 days following transduction. The GD2-CAR construct coexpresses the QBend10 epitope from CD34, allowing detection by flow cytometry. Transduction efficiency was determined by the percentage of QBend10+ in the T cell population gate compared to control non-transduced cells. (B–D) Mean transduction efficiency using CD3/CD28 antibody, ZOL, or ConA activation methods, respectively. Each data point represents an individual donor (n = 9) and each horizontal line is the mean. (E–G) Bulk populations of GD2-CAR-transduced T cells stimulated by CD3/CD28 antibody (E), ZOL (F), and ConA (G) specifically lyse the GD2-expressing neuroblastoma cell line, LAN1, in 4-hr 51Cr release assay. NTD, non-transduced T cells; TD, transduced GD2-CAR+ T cells (data represented as mean ± SEM; 3–5 individual donors in triplicate). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/29310916), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Human Human CD34 APC-conjugated Antibody by Flow Cytometry

Detection of Human Human CD34 APC-conjugated Antibody by Flow Cytometry

Memory Phenotype and Exhaustion Marker Expression on Expanded CD3+ alpha beta, V delta 1+, and V delta 2+ Live T Cells(A) Representative flow cytometry dot plot showing gating of T cell subtypes ( alpha beta, V delta 1+, and V delta 2+) and contour plots of the corresponding subtype memory phenotype (N, naive; CM, central memory; EM, effector memory; TEMRA, terminally differentiated effector memory) according to expression of CD27 and CD45RA. (B–D) memory phenotypes of pre-expanded PBMCs (B), post-expansion non-transduced (NTD) cells (C), and post-expansion GD2-CAR-transduced cells (D). alpha beta cells were stimulated with CD3/CD28 antibody, V delta 1 cells were stimulated with ConA, and V delta 2 cells were stimulated with ZOL (data represented as mean ± SEM; alpha beta and V delta 2, n = 6; V delta 1, n = 3). (E and F) Expanded V delta 1+ cells transduced with CAR after ConA stimulation express significantly fewer exhaustion markers (PD1 and TIM3) than alpha beta and V delta 2+ CAR-T cells. (E) Flow cytometry plots from a representative donor. alpha beta cells were stimulated with CD3/CD28 antibody, V delta 1+ cells were stimulated with ConA, and V delta 2+ cells were stimulated with ZOL. (F) PD1 and TIM3 expression on TD and NTD T cells 13 days following activation (data represented as mean ± SEM; alpha beta and V delta 2+, n = 6; V delta 1+, n = 3; p value for significance comparing double-negative populations). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/29310916), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Human CD34 by Flow Cytometry

Detection of Human CD34 by Flow Cytometry

alpha beta, V delta 1+, and V delta 2+ T Cells Are Efficiently Transduced with GD2-CAR following Activation with CD3/CD28 Antibody, ZOL, or ConA, and Bulk Populations Are Cytotoxic to Neuroblastoma Cells(A) Representative flow cytometry dot plot showing transduction efficiency of ZOL-expanded non-transduced and GD2-CAR+-transduced PBMCs. V delta 2+ populations were gated on CD3+ live cells 8 days following transduction. The GD2-CAR construct coexpresses the QBend10 epitope from CD34, allowing detection by flow cytometry. Transduction efficiency was determined by the percentage of QBend10+ in the T cell population gate compared to control non-transduced cells. (B–D) Mean transduction efficiency using CD3/CD28 antibody, ZOL, or ConA activation methods, respectively. Each data point represents an individual donor (n = 9) and each horizontal line is the mean. (E–G) Bulk populations of GD2-CAR-transduced T cells stimulated by CD3/CD28 antibody (E), ZOL (F), and ConA (G) specifically lyse the GD2-expressing neuroblastoma cell line, LAN1, in 4-hr 51Cr release assay. NTD, non-transduced T cells; TD, transduced GD2-CAR+ T cells (data represented as mean ± SEM; 3–5 individual donors in triplicate). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/29310916), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Human CD34 by Flow Cytometry

Detection of Human CD34 by Flow Cytometry

Memory Phenotype and Exhaustion Marker Expression on Expanded CD3+ alpha beta, V delta 1+, and V delta 2+ Live T Cells(A) Representative flow cytometry dot plot showing gating of T cell subtypes ( alpha beta, V delta 1+, and V delta 2+) and contour plots of the corresponding subtype memory phenotype (N, naive; CM, central memory; EM, effector memory; TEMRA, terminally differentiated effector memory) according to expression of CD27 and CD45RA. (B–D) memory phenotypes of pre-expanded PBMCs (B), post-expansion non-transduced (NTD) cells (C), and post-expansion GD2-CAR-transduced cells (D). alpha beta cells were stimulated with CD3/CD28 antibody, V delta 1 cells were stimulated with ConA, and V delta 2 cells were stimulated with ZOL (data represented as mean ± SEM; alpha beta and V delta 2, n = 6; V delta 1, n = 3). (E and F) Expanded V delta 1+ cells transduced with CAR after ConA stimulation express significantly fewer exhaustion markers (PD1 and TIM3) than alpha beta and V delta 2+ CAR-T cells. (E) Flow cytometry plots from a representative donor. alpha beta cells were stimulated with CD3/CD28 antibody, V delta 1+ cells were stimulated with ConA, and V delta 2+ cells were stimulated with ZOL. (F) PD1 and TIM3 expression on TD and NTD T cells 13 days following activation (data represented as mean ± SEM; alpha beta and V delta 2+, n = 6; V delta 1+, n = 3; p value for significance comparing double-negative populations). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/29310916), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Human CD34 by Flow Cytometry

Detection of Human CD34 by Flow Cytometry

alpha beta, V delta 1+, and V delta 2+ T Cells Are Efficiently Transduced with GD2-CAR following Activation with CD3/CD28 Antibody, ZOL, or ConA, and Bulk Populations Are Cytotoxic to Neuroblastoma Cells(A) Representative flow cytometry dot plot showing transduction efficiency of ZOL-expanded non-transduced and GD2-CAR+-transduced PBMCs. V delta 2+ populations were gated on CD3+ live cells 8 days following transduction. The GD2-CAR construct coexpresses the QBend10 epitope from CD34, allowing detection by flow cytometry. Transduction efficiency was determined by the percentage of QBend10+ in the T cell population gate compared to control non-transduced cells. (B–D) Mean transduction efficiency using CD3/CD28 antibody, ZOL, or ConA activation methods, respectively. Each data point represents an individual donor (n = 9) and each horizontal line is the mean. (E–G) Bulk populations of GD2-CAR-transduced T cells stimulated by CD3/CD28 antibody (E), ZOL (F), and ConA (G) specifically lyse the GD2-expressing neuroblastoma cell line, LAN1, in 4-hr 51Cr release assay. NTD, non-transduced T cells; TD, transduced GD2-CAR+ T cells (data represented as mean ± SEM; 3–5 individual donors in triplicate). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/29310916), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Human CD34 by Flow Cytometry

Detection of Human CD34 by Flow Cytometry

Memory Phenotype and Exhaustion Marker Expression on Expanded CD3+ alpha beta, V delta 1+, and V delta 2+ Live T Cells(A) Representative flow cytometry dot plot showing gating of T cell subtypes ( alpha beta, V delta 1+, and V delta 2+) and contour plots of the corresponding subtype memory phenotype (N, naive; CM, central memory; EM, effector memory; TEMRA, terminally differentiated effector memory) according to expression of CD27 and CD45RA. (B–D) memory phenotypes of pre-expanded PBMCs (B), post-expansion non-transduced (NTD) cells (C), and post-expansion GD2-CAR-transduced cells (D). alpha beta cells were stimulated with CD3/CD28 antibody, V delta 1 cells were stimulated with ConA, and V delta 2 cells were stimulated with ZOL (data represented as mean ± SEM; alpha beta and V delta 2, n = 6; V delta 1, n = 3). (E and F) Expanded V delta 1+ cells transduced with CAR after ConA stimulation express significantly fewer exhaustion markers (PD1 and TIM3) than alpha beta and V delta 2+ CAR-T cells. (E) Flow cytometry plots from a representative donor. alpha beta cells were stimulated with CD3/CD28 antibody, V delta 1+ cells were stimulated with ConA, and V delta 2+ cells were stimulated with ZOL. (F) PD1 and TIM3 expression on TD and NTD T cells 13 days following activation (data represented as mean ± SEM; alpha beta and V delta 2+, n = 6; V delta 1+, n = 3; p value for significance comparing double-negative populations). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/29310916), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human CD34 APC‑conjugated Antibody

Application
Recommended Usage

Flow Cytometry

10 µL/106 cells
Sample: Human peripheral blood mononuclear cells (PBMCs) and KG‑1a human acute myelogenous leukemia cell line

Spectra Viewer

Plan Your Experiments

Use our spectra viewer to interactively plan your experiments, assessing multiplexing options. View the excitation and emission spectra for our fluorescent dye range and other commonly used dyes.

Spectra Viewer

Flow Cytometry Panel Builder

Bio-Techne Knows Flow Cytometry

Save time and reduce costly mistakes by quickly finding compatible reagents using the Panel Builder Tool.

Advanced Features

  • Spectra Viewer - Custom analysis of spectra from multiple fluorochromes
  • Spillover Popups - Visualize the spectra of individual fluorochromes
  • Antigen Density Selector - Match fluorochrome brightness with antigen density
Build Your Panel Now

Formulation, Preparation, and Storage

Purification

Protein A or G purified from hybridoma culture supernatant

Formulation

Supplied in a saline solution containing BSA and Sodium Azide.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Protect from light. Do not freeze.
  • 12 months from date of receipt, 2 to 8 °C as supplied.

Background: CD34

The CD34 family of cell surface transmembrane proteins includes the hematopoietic progenitor cell antigen CD34, Podocalyxin, and Endoglycan. This single-pass sialomucin‑like transmembrane protein is heavily glycosylated and phosphorylated by Protein kinase C (PKC). CD34 is a 115 kDa glycoprotein found on multipotent precursors, bone marrow stromal cells, embryonic fibroblasts, vascular endothelia, as well as some populations of mesenchymal stem cells, and tumor cell lines. CD34 is involved in the adhesion of stem cells to the bone marrow extracellular matrix or to stromal cells.

Alternate Names

CD34, HPCA1

Entrez Gene IDs

947 (Human); 12490 (Mouse); 305081 (Rat); 397160 (Porcine); 415130 (Canine)

Gene Symbol

CD34

Additional CD34 Products

Product Documents for Human CD34 APC‑conjugated Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human CD34 APC‑conjugated Antibody

For research use only

Citations for Human CD34 APC‑conjugated Antibody

Customer Reviews for Human CD34 APC‑conjugated Antibody

There are currently no reviews for this product. Be the first to review Human CD34 APC‑conjugated Antibody and earn rewards!

Have you used Human CD34 APC‑conjugated Antibody?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies